SANIFIT

📍 Palma de Mallorca, Spain🗓 Founded 2007👥 28 employees💰 Last funded Jul 2019
Biotechnology🌐 sanifit.com
Website LinkedIn
Sanifit is a biopharmaceutical company focused on the development of SNF472. The company was founded in 2007 as a spin-off of the University of the Balearic Islands and expanded its activities in the USA in 2016 with the incorporation of a subsidiary with offices in San Diego. SNF472 is an experimental drug for the treatment of cardiovascular diseases linked to calcification in the End Stage Renal Disease population undergoing haemodialysis. Sanifit has completed Phase I studies with healthy volunteers and haemodialysis patients, and after a recent series C funding round of $41.3M (€36.6M), Sanifit has launched two Phase II programs in ESRD and in the orphan space in calciphylaxis. For more information please visit www.sanifit.com
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2007
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Spain
1
Frequently asked questions
Who invested in SANIFIT?
SANIFIT has 1 investors on record on gritt.io.
When did SANIFIT last raise funding?
The most recent investment in SANIFIT recorded on gritt.io was in July 2019.
When was SANIFIT founded?
SANIFIT was founded in 2007.
What industry is SANIFIT in?
SANIFIT operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is SANIFIT based?
SANIFIT is headquartered in Palma de Mallorca, Spain.